Arcturus Therapeutics Holdings Inc (ARCT) Company Profile & Statistics

Arcturus Therapeutics Holdings Inc
ARCT
(Nasdaq - US)
N/A
26.51
+0.34 (+1.30%)
in:usd•As of: Apr 26, 2024 15:59 UTC -4
Open
25.97
High
26.86
Low
25.89

About Arcturus Therapeutics Holdings Inc

CEO

Joseph E. Payne

Headquarters

10628 science center drive, suite 250

san diego, ca 92121, united states

Auditor

Ernst & Young, LLP

Employees

180

Share Holders

Website

www.arcturusrx.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Arcturus Therapeutics Ltd. is a preclinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of RNA medicines using proprietary lipid-mediated delivery system LUNAR(TM) and UNA Oligomer chemistry technologies. Arcturus Therapeutics Ltd, formerly known as Alcobra Ltd, is based in San Diego, CA.

Arcturus Therapeutics Holdings Inc Statistics

Valuation Measures

Market Capitalization ²	713.65M
Enterprise Value	366.64M
Enterprise Value/EBITDA (ttm)	-4.87
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	2.51
Price to Sales (ttm)	4.14
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	100.00%
Operating Margin (ttm)	-31.43%
Profit Margin (ttm)	-127.56%
Return on Equity (ttm)	-18.22%
Return on Invested Capital (ttm)	-12.62%
Return on Assets (ttm)	-11.95%

Income Statement

Revenue (ttm)	166.80M
Revenue Per Share (ttm)	6.20
Gross Profit (ttm)	166.80M
EBITDA (ttm)³	-75.25M
Net Income Avi to Common (ttm)	-29.73M
Diluted EPS (ttm)	-1.04

Share Statistics

Beta (5Y Monthly)	2.60
52-Week Change	2.24%
S&P500 52-Week Change	25.74%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	26.92M
Dividend Yield	0.00%
Float ⁴	23.20M
% Held by Insiders	13.80%
% Held by Institutions	94.54%

Balance Sheet

Total Cash (mrq)	347.00M
Total Cash Per Share (mrq)	12.89
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	4.72%
Quick Ratio (mrq)	4.72%
Book Value Per Share (mrq)	10.38

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.68
Free Cash Flow (ytd)	-21.00M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Arcturus Therapeutics Holdings Inc

Trade With A Regulated Broker